SCHEMBL21396939

SCHEMBL21396939

N#Cc1ccc(N2c3ccccc3[Si](c3ccccc3)(c3ccccc3)c3ccccc32)c(-c2cnccc2N2c3ccccc3[Si](c3ccccc3)(c3ccccc3)c3ccccc32)c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.34
CYP11B1 P15538 5/20 0.34
CYP19A1 P11511 4/20 0.34
SLC22A12 Q96S37 4/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
CYP17A1 P05093 1/20 0.32
CHUK O15111 1/20 0.32
EGFR P00533 1/20 0.32
CASP3 P42574 1/20 0.30
CYP3A4 P08684 2/20 0.30
CYP2D6 P10635 2/20 0.30
CYP2C19 P33261 2/20 0.30
CYP1A2 P05177 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396795 0.89 CYP11B1 (0.37) CYP11B2CYP11B1CYP19A1SLC22A12GABRA1
SCHEMBL21396643 0.88 CYP11B1 (0.38) CYP11B2CYP11B1CYP19A1SLC22A12GABRA1
SCHEMBL21927763 0.80 MEN1 (0.34) SLC22A12GABRG2GABRB3GABRA5GABRA3
SCHEMBL21397022 0.79 GABRA1 (0.33) CYP11B2CYP11B1CYP19A1GABRA1GABRG2
SCHEMBL21928016 0.79 ATR (0.33) SLC22A12CYP3A4CYP1A2
SCHEMBL21397048 0.79 CYP11B2 (0.37) CYP11B2CYP11B1SLC22A12GABRA1GABRG2
SCHEMBL21396792 0.79 CYP11B2 (0.37) CYP11B2CYP11B1CYP19A1SLC22A12GABRA1
SCHEMBL19344961 0.78 CA1 (0.32) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL21927754 0.78 UCHL1 (0.37) SLC22A12CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL21397002 0.77 CYP11B2 (0.38) CYP11B2CYP11B1CYP19A1SLC22A12GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLC18A1 CYP11B2 1859/4885CYP11B1 1877/4885CYP19A1 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.